MarketPeel
Insider Trading Intelligence
JN

James Andrew Nathanielsz

PPCB
CEO/CFO · PROPANC BIOPHARMA, INC. · CIK 0001554937
FILING MIX · LIFETIME100%/0%
BUYS
2
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Aug 2021
HOLDINGS NOW
5,928,004
AVG SELL PX
TRADE KIND
SHOWING 2 / 2
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for James Andrew Nathanielsz. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
PPCB · 5,928,004 shares · as of Aug 17, 2021
01,482,0012,964,0024,446,0035,928,004SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
FLOW · 2 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
PPCB
PROPANC BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
2,800,0002,800,000Aug 17, 2021Aug 19, 2021
PPCB
PROPANC BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
5,928,0005,928,004Aug 17, 2021Aug 19, 2021
Other insiders · PPCB
Loading peer insiders…
About this filer
CIK 0001554937
ROLE
CEO/CFO
PRIMARY
PPCB
COMPANIES
1
ACTIVE SINCE
Aug 2021
MARKETPEEL · /INSIDER/0001554937DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback